Brenton Karl Ahrens's Net Worth
$55.2 Million
Who is Brenton Karl Ahrens?
Brenton Karl Ahrens has an estimated net worth of $55.2 Million. This is based on reported shares across multiple companies, which include DEXCOM INC, Iterum Therapeutics plc, Durata Therapeutics, Inc., and ACTIVE NETWORK INC.
SEC CIK
Brenton Karl Ahrens's CIK is 0001322927
Past Insider Trading and Trends
2018 was Brenton Karl Ahrens's most active year for acquiring shares with 5 total transactions. Brenton Karl Ahrens's most active month to acquire stocks was the month of April. 2022 was Brenton Karl Ahrens's most active year for disposing of shares, totalling 9 transactions. Brenton Karl Ahrens's most active month to dispose stocks was the month of April. 2018 saw Brenton Karl Ahrens paying a total of $6,586,528.00 for 1,739,324 shares, this is the most they've acquired in one year. In 2011 Brenton Karl Ahrens cashed out on 8,328,619 shares for a total of $20,575,515.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ACTIVE NETWORK INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.68% | -194.49K |
$16.00 | -$3,111,814.40 | 5.09M |
Mar 2 - Mar 5
| |||
Form 4
| -2.55% | -138.19K |
$16.00 | -$2,211,224.42 | 5.28M |
Feb 29 - Mar 1
| |||
Form 4
| -2.53% | -140.70K |
$15.92 | -$2,239,632.15 | 5.42M |
Feb 27 - Feb 28
| |||
Form 4
|
∞
| 5.59M |
$15.00 | -$20,575,515.00 | 5.59M |
May 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DEXCOM INC (DXCM) Snapshot price: $126.195
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 13
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 13
| |||
Form 4
|
∞
| 3.09M |
—
|
—
| 3.09M |
Apr 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Iterum Therapeutics plc (ITRM) Snapshot price: $1.7283
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 25
| |||
Form 4
| -100.00% | -37.25K |
$1.82 | -$67,930.20 |
0
|
Sep 16 - Sep 20
| |||
Form 4
| -54.71% | -45.00K |
$2.09 | -$93,846.00 | 37.25K |
Sep 13 - Sep 15
| |||
Form 4
| -28.82% | -33.30K |
$2.31 | -$76,802.52 | 82.25K |
Sep 8 - Sep 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
∞
| 6.15K |
—
|
—
| 6.15K |
May 24
| |||
Form 4
|
∞
| 1.73M |
$13.00 |
—
| 1.73M |
May 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Durata Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.91M |
—
|
—
|
0
|
Nov 17
| |||
Form 4
|
∞
| 5.03K |
$2.08 | $10,470.72 | 5.03K |
Aug 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
∞
| 1.9M |
$9.00 |
—
| 1.9M |
Feb 28 - Jul 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||